Herpes zoster in patients with inflammatory arthritides or ulcerative colitis treated with tofacitinib, baricitinib or upadacitinib: a systematic review of clinical trials and real-world studies

JAK inhibitors (JAKi) are new targeted-synthetic drugs, approved for various immune-mediated inflammatory diseases (IMIDs), including inflammatory arthritides (rheumatoid arthritis—RA, psoriatic arthritis—PsA, ankylosing spondylitis—AS) and ulcerative colitis (UC). JAKi have been associated with inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gialouri, Chrysoula G., Moustafa, Savvina, Thomas, Konstantinos, Hadziyannis, Emilia, Vassilopoulos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968274/
https://www.ncbi.nlm.nih.gov/pubmed/36635577
http://dx.doi.org/10.1007/s00296-022-05270-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968274/
https://www.ncbi.nlm.nih.gov/pubmed/36635577
http://dx.doi.org/10.1007/s00296-022-05270-6

Ejemplares similares